EVLO

Evelo Biosciences, Inc.

0.37 USD
+0.32 (+620.16%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Evelo Biosciences, Inc. stock is up 636% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 16.67% of the previous 5 February’s closed higher than January.

About Evelo Biosciences, Inc.

Evelo Biosciences, Inc. discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. The company also develops EDP1815, a whole-microbe candidate for the. treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19.